Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.’s Net Profit Rose 2.9% in 2022

Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd. (浙江我武生物科技股份有限公司) (300357.SZ) reported a net profit of 335.7 million yuan in 2022, up 2.9% year-on-year.

Meanwhile, the company posted 896 million yuan in revenue, up 10.9% year-on-year.

At the end of the reporting period, it had 2.2 billion yuan in total assets and 170.8 million yuan in total liabilities, with a liability-to-asset ratio of 7.8%.